ALTHEA GROUP HOLDINGS LIMITED (AGH) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Neutral

just now

Althea Group (ASX:AGH) Trims Its Offshore Footprint

Highlights Divestment of a United Kingdom subsidiary narrows the group to its stronger operating markets. Balance sheet repair has displaced expansion as the organising priority. German and Australian demand now carry the weight of the revenue base. Althea Group (ASX:AGH), the Australian supplier of regulated medicinal cannabis products with operations spanning domestic distribution, European markets and a North American manufacturing arm, has drawn attention across the segment after divestin...

Kalkine

Neutral

just now

What Is Bringing Althea Group (ASX:AGH), MGC Pharmaceuticals (ASX:MXC), Ecofibre (ASX:EOF) and Creso Pharma (ASX:CPH) Into Focus Now?

Highlights Althea Group and MGC Pharmaceuticals are being assessed through operational delivery, strategic priorities and the quality of their underlying platforms. Ecofibre and Creso Pharma highlight how sector conditions can create different requirements across established and emerging business models. Capital discipline, customer relevance and consistent execution remain central as the four companies progress their current work programs. Australias market conversation is being shaped by re...

ASX

Neutral

just now

Quarterly Activities/Appendix 4C Cash Flow Report

other announcement

ASX

Neutral

just now

Change of Director's Interest Notice - B Katzman

director_dealing announcement

ASX

Neutral

just now

Cleansing notice

other announcement

Kalkine

Neutral

just now

Althea Group (ASX:AGH): Why Is It Leading the Cannabis Stocks Conversation?

Highlights Industry consolidation and regulatory scrutiny are reshaping Australia's medicinal cannabis sector. Althea Group, Vitura Health and IDT Australia are drawing attention through manufacturing, distribution and export capabilities. The new financial year is shifting the focus towards execution, compliance and operational credibility. Australia's medicinal cannabis sector is entering ...

Kalkine

Neutral

just now

Althea Group (ASX:AGH) trims UK business in Montu deal: What's next?

Highlights Althea Group (ASX:AGH) has agreed to divest its UK and Ireland clinic business, MyAccess Clinics, to Australian medicinal cannabis operator Montu. The transaction forms part of the company's broader restructuring strategy aimed at lowering operating costs and sharpening its business focus. The move reflects the ongoing consolidation trend across the ASX Cannabis Stocks sector as companies streamline operations. ...

Kalkine

Neutral

just now

What Althea (ASX:AGH) Faces as TGA Tightens Rules?

Highlights The TGA is sharpening its focus on medicinal cannabis compliance. Telehealth prescribing is emerging as a key pressure point for the sector. Stronger quality controls may reshape Australia’s listed cannabis landscape. TGA reform is reshaping Australia’s medicinal cannabis sector as tighter compliance, telehealth scrutiny and stronger product standards place ASX cannabis companies ...